| Literature DB >> 22375094 |
Porkodi Panneerselvam1, Praveen Bawankar, Surashree Kulkarni, Swati Patankar.
Abstract
The Plasmodium falciparum genome being AT-rich, the presence of GC-rich regions suggests functional significance. Evolution imposes selection pressure to retain functionally important coding and regulatory elements. Hence searching for evolutionarily conserved GC-rich, intergenic regions in an AT-rich genome will help in discovering new coding regions and regulatory elements. We have used elevated GC content in intergenic regions coupled with sequence conservation against P. reichenowi, which is evolutionarily closely related to P. falciparum to identify potential sequences of functional importance. Interestingly, ~30% of the GC-rich, conserved sequences were associated with antigenic proteins encoded by var and rifin genes. The majority of sequences identified in the 5' UTR of var genes are represented by short expressed sequence tags (ESTs) in cDNA libraries signifying that they are transcribed in the parasite. Additionally, 19 sequences were located in the 3' UTR of rifins and 4 also have overlapping ESTs. Further analysis showed that several sequences associated with var genes have the capacity to encode small peptides. A previous report has shown that upstream peptides can regulate the expression of var genes hence we propose that these conserved GC-rich sequences may play roles in regulation of gene expression.Entities:
Keywords: Plasmodium; antigenic variation; comparative genomics; genome bias; regulatory elements
Year: 2011 PMID: 22375094 PMCID: PMC3283219 DOI: 10.4137/EBO.S8162
Source DB: PubMed Journal: Evol Bioinform Online ISSN: 1176-9343 Impact factor: 1.625
BLAST analysis of antigenic proteins.
| Gene ID and the gene product | No of hits with | No of hits with | Best hit with | ||
|---|---|---|---|---|---|
| MAL13P1.1 PfEMP1 | 2 | 0.027 | 109 | 2e–87 | Pr_3502696.c000023469.Contig1 |
| PF07_0051 PfEMP1 | 27 | 3e–5 | 107 | 7e–54 | Pr_3502696.c000023041.Contig1 |
| MAL13P1.2 RIFIN | 2 | 0.017 | 194 | e-128 | Pr_3502696.c000027339.Contig1 |
| PFF0850c RIFIN | 0 | – | 37 | 2e–95 | Pr_3502696.c000023726.Contig1 |
| MAL13P1.505 STEVOR | 1 | 0.015 | 35 | e-140 | Pr_3502696.c000023791.Contig1 |
| PFI0045c STEVOR | 4 | 0.014 | 34 | e-136 | Pr_3502696.c000023791.Contig1 |
Note: Two members of the PfEMP, rifin and stevor families were chosen arbitrarily from the P. falciparum genome and BLAST was performed against the genomes of Plasmodium yoelii and Plasmodium reichenowi.
Conserved GC rich sequence associated with var genes.
| Candidate | Location | PfEMP1 Associated | GC% | Identity | Associated ESTs |
|---|---|---|---|---|---|
| PfNC1.1var | Chr 1: 29631 to 29730 | PFA0005w | 37 | 58/100 | AU088275 |
| PfNC1.2var | Chr 1: 616621 to 616710 | PFA0765c | 38.9 | 33/90 | AU088275 and AU087013 |
| PfNC2.1var | Chr 2: 25101 to 25230 | PFB0010w | 40.8 | 56/130 | AU087013 and AU088275 |
| PfNC2.2var | Chr 2: 923651 to 923750 | PFB1055c | 42 | 58/100 | AU087013 and AU088275 |
| PfNC3.1var | Chr 3: 33511 to 33640 | PFC0005w | 38.5 | 72/130 | AU088275 |
| PfNC3.2var | Chr 3: 1034931 to 1035030 | PFC1120c | 41 | 42/100 | AU088275 |
| PfNC4.1var | Chr 4: 35061 to 35150 | PFD0005w | 46.7 | 32/90 | AU088275 |
| PfNC4.2var | Chr 4: 606841 to 606930 | PFD0635c | 42.2 | 38/90 | AU088275 |
| PfNC4.3var | Chr 4: 970091 to 970160 | PFD1005c | 35 | 34/70 | AU088275 |
| PfNC4.4var | Chr 4: 981221 to 981290 | PFD1015c | 37 | 36/70 | – |
| PfNC4.5var | Chr 4: 1183861 to 1183950 | PFD1245c | 45.6 | 31/90 | AU088275 |
| PfNC6var | Chr 6: 3401 to 3500 | PFF0010w | 42 | 38/100 | AU088275 |
| PfNC7.1var | Chr 7: 30531 to 30670 | MAL7P1.212 | 37.9 | 81/140 | AU088275 and AU087013 |
| PfNC7.2var | Chr 7: 605971 to 606040 | MAL7P1.50 | 37 | 35/70 | AU088275 |
| PfNC7.3var | Chr 7: 614461 to 614570 | PF07_0050 | 40 | 38/110 | AU088275 |
| PfNC7.4var | Chr 7: 644311 to 644440 | MAL7P1.55 | 41.5 | 43/130 | AU087013 |
| PfNC8.1var | Chr 8: 22251 to 22330 | PF08_0142 | 41.3 | 41/80 | AU087013 |
| PfNC8.2var | Chr 8: 441381 to 441450 | PF08_0106 | 38 | 34/70 | AU087013 |
| PfNC8.3var | Chr 8: 1399241 to 1399340 | MAL8P1.220 | 38 | 38/100 | AU088275 and AU087013 |
| PfNC9.1var | Chr 9: 19931 to 20070 | PFI0005w | 40.7 | 92/140 | AU088275 |
| PfNC9.2var | Chr 9: 1503331 to 1503430 | PFI1830c | 37 | 38/100 | AU088275 |
| PfNC10var | Chr 10: 28351 to 28490 | PF10_0001 | 36.4 | 76/100 | AU088275 |
| PfNC11var | Chr 11: 24021 to 24150 | PF11_0007 | 40 | 67/130 | AU088275 |
| PfNC12.1var | Chr 12: 32601 to 32670 | PFL0020w | 37.1 | 41/70 | AU088275 |
| PfNC12.2var | Chr 12: 774191 to 774300 | PFL0935c | 38.2 | 53/110 | AU088275 and AU087013 |
| PfNC12.3var | Chr 12: 1704411 to 1704490 | PFL1955w | 46.3 | 36/80 | AU088275 and AU087013 |
| PfNC12.4var | Chr 12: 2248951 to 2249040 | PFL2665c | 45.6 | 56/90 | AU088275 |
Note: All candidates are found in the 5′ UTRs of var genes and are within 150 bases of the start codon.
Figure 1Sequence alignment of proximal upstream regions of upsB var genes.
Notes: The box shows that conserved GC-rich sequences contain the putative upstream ORF MYATI. Grey highlights show-conserved sequences, indicating that sequences flanking the putative uORF are less conserved than the regions encoding the uORF. The annotated start codon is highlighted in grey.
Figure 2BLAST result of PfNC12.4var against the Plasmodium reichenowi genome.
Note: The regions of conservation are shown with stars and the uORF is highlighted in grey.
Conserved GC rich regions associated with rifin genes.
| S.no | Candidate | Associated RIFIN | GC% | Identity | Associated ESTs |
|---|---|---|---|---|---|
| PfNC1.1rif | Chr 1: 62341 to 62410 | PFA0045c | 35% | 36/70 | – |
| PfNC1.2rif | Chr 1: 81921 to 81990 | PFA0080c | 38% | 55/70 | – |
| PfNC2rif | Chr 2: 32951 to 33020 | PFB0015c | 35% | 36/70 | – |
| PfNC3rif | Chr 3: 1025611 to 1025680 | PFC1115w | 35% | 34/70 | BI816203 |
| PfNC4rif | Chr 4: 67831 to 67940 | PFD0025w | 37.3% | 78/110 | – |
| PfNC6rif | Chr 6: 1352101 to 1352170 | PFF1575w | 37% | 50/70 | – |
| PfNC7.1rif | Chr 7: 45441 to 45540 | MAL7P1.215 | 35% | 79/100 | – |
| PfNC7.2rif | Chr 7: 55261 to 55330 | MAL7P1.217 | 37% | 45/70 | BQ577081 |
| PfNC7.3rif | Chr 7: 1454751 to 1454820 | PF07_0134 | 37% | 47/70 | – |
| PfNC9.1rif | Chr 9: 42361 to 42460 | PFI0025c | 34% | 80/100 | – |
| PfNC9.2rif | Chr 9: 1479191 to 1479290 | PFI1810w | 35% | 81/100 | – |
| PfNC10.1rif | Chr 10: 39021 to 39090 | PF10_0002w | 35.7% | 89/100 | – |
| PfNC10.2rif | Chr 10: 47981 to 48050 | PF10_0005 | 35.7% | 88/100 | – |
| PfNC10.3rif | Chr 10: 1623881 to 1623950 | PF10_0398 | 35.7% | 98/100 | – |
| PfNC12.1rif | Chr 12: 43711 to 43790 | PFL0025c | 33.8% | 92/100 | BQ577081 |
| PfNC12.2rif | Chr 12: 2239401 to 2239480 | PFL2660w | 35% | 87/100 | – |
| PfNC13.1rif | Chr 13: 30631 to 30700 | MAL13P1.2 | 37.1% | 94/100 | BQ577081 |
| PfNC13.2rif | Chr 13: 53591 to 53670 | PF13_0006 | 40% | 95/100 | – |
Note: All candidates are found in the 3′ UTRs of rifin genes.
List of 151 GC-rich sequences proximal to annotated genes identified in P. falciparum.
| S.no | Name of the candidate | Proximal gene and orientation | Proximal gene | Distance from the proximal gene | GC% and identity |
|---|---|---|---|---|---|
| 1 | Chr 1: 62341 to 62410 | RIFIN | 10 | 35% and 36/70 | |
| 2 | Chr 1: 81921 to 81990 | RIFIN | 8 | 38% and 55/70 | |
| 3 | Chr 1: 197781 to 197850 | Ubiquitin carboxyl terminal hydrolase | 5 | 35% and 62/70 | |
| 4 | Chr 1: 556971 to 557100 | PfEMP1 | 320 | 35% and 126/130 | |
| 5 | Chr 1: 616621 to 616710 | PfEMP1 | 8 | 38.9% and 33/90 | |
| 6 | Chr 1: 29631 to 29730 | PfEMP1 | 3 | 37% and 58/100 | |
| 7 | Chr 1: 503731 to 503800 | Hypothetical protein | 35% and 40/70 | ||
| 8 | Chr 2: 25101 to 25230 | PfEMP1 | 2 | 40.8% and 56/130 | |
| 9 | Chr 2: 32951 to 33020 | RIFIN | 10 | 35% and 36/70 | |
| 10 | Chr 2: 54331 to 54410 | STEVOR isoform gam beta | 8 | 43.8% and 73/80 | |
| 11 | Chr 2: 147571 to 147640 | Hypothetical protein | 7 | 37% and 58/70 | |
| 12 | Chr 2: 165911 to 165990 | Hypothetical protein | 154 | 35% and 57/80 | |
| 13 | Chr 2: 197361 to 197430 | Hypothetical protein | 445 | 35% and 66/70 | |
| 14 | Chr 2: 301801 to 301970 | Cysteine protease putative | 8 | 40.6% and 162/170 | |
| 15 | Chr 2: 473501 to 473600 | Protein kinase putative | 10 | 37% and 93/100 | |
| 16 | Chr 2: 923651 to 923750 | PfEMP1 | 3 | 42% and 58/100 | |
| 17 | Chr 3: 8031 to 8160 | Hypothetical protein | 234 | 36.2% and 93/130 | |
| 18 | Chr 3: 8461 to 8540 | Hypothetical protein | 35% and 62/80 | ||
| 19 | Chr 3: 10961 to 11050 | Hypothetical protein | 216 | 34.4% and 74/90 | |
| 20 | Chr 3: 33511 to 33640 | PfEMP1 | 1 | 38.5% and 72/130 | |
| 21 | Chr 3: 443031 to 443120 | Hypothetical protein | 197 | 34.4% and 80/90 | |
| 22 | Chr 3: 540901 to 540980 | Hypothetical protein | 35% and 40/50 | ||
| 23 | Chr 3: 686651 to 686720 | Protein kinase putative | 107 | 38% and 31/70 | |
| 24 | Chr 3: 691491 to 691560 | Protein kinase putative | 3 | 35% and 66/70 | |
| 25 | Chr 3: 1025611 to 1025680 | Rifin | 12 | 35% and 34/70 | |
| 26 | Chr 3: 1034931 to 1035030 | Var gene | 7 | 41% and 42/100 | |
| 27 | Chr 3: 1046441 to 1046510 | Hypothetical protein | 351 | 35% and 35/70 | |
| 28 | Chr 3: 1051191 to 1051280 | Hypothetical protein | 213 | 34.4% and 65/90 | |
| 29 | Chr 4: 35061 to 35150 | PfEMP1 | 3 | 46.7% and 32/90 | |
| 30 | Chr 4: 67831 to 67940 | RIFIN | 445 | 37.3% and 78/110 | |
| 31 | Chr 4: 311851 to 311920 | Hypothetical protein and lysine decarboxylase | 36 and 298 | 35% and 42/70 | |
| 32 | Chr 4: 336301 to 336410 | Sexual stage specific precursor and hypothetical protein | 135 and 5 | 39.1% and 106/110 | |
| 33 | Chr 4: 500431 to 500520 | Hypothetical protein | 159 | 35.6% and 65/90 | |
| 34 | Chr 4: 606841 to 606930 | PfEMP1 | 9 | 42.2% and 38/90 | |
| 35 | Chr 4: 667311 to 667410 | GTP binding protein | 197 | 34% and 95/100 | |
| 36 | Chr 4: 851901 to 851970 | Hypothetical protein | 404 | 35% and 54/70 | |
| 37 | Chr 4: 862591 to 862660 | CGI141 protein homolog, and hypothetical protein | 322 and 218 | 35% and 56/70 | |
| 38 | Chr 4: 970091 to 970160 | PfEMP 1 | 41 | 35% and 34/70 | |
| 39 | Chr 4: 981221 to 981290 | PfEMP1 | 191 | 37% and 36/70 | |
| 40 | Chr 4: 1064251 to 1064380 | Hypothetical protein | 37.7% and 80/130 | ||
| 41 | Chr 4: 1183861 to 1183950 | PfEMP1 | 13 | 45.6% and 31/90 | |
| 43 | Chr 5: 619951 to 620030 | Hypothetical protein | 8 | 38.8% and 56/80 | |
| 44 | Chr 6: 3401 to 3500 | PfEMP1 | 3 | 42% and 38/100 | |
| 45 | Chr 6: 296831 to 296920 | Translation initiation factor IF2 | 38 | 34.4% and 77/90 | |
| 46 | Chr 6: 661791 to 661880 | Hypothetical proteins | 6 and 551 | 31.1% and 55/90 | |
| 47 | Chr 6: 672491 to 672560 | Hypothetical protein | 35% and 64/70 | ||
| 48 | Chr 6: 1352101 to 1352170 | RIFIN | 80 | 37% and 50/70 | |
| 49 | Chr 7: 30531 to 30670 | PfEMP1 | 3 | 37.9% and 81/140 | |
| 50 | Chr 7: 45441 to 45540 | RIFIN | 447 | 35% and 79/100 | |
| 51 | Chr 7: 55261 to 55330 | RIFIN | 1 | 37% and 45/70 | |
| 52 | Chr 7: 98671 to 98740 | Hypothetical protein | 215 | 37% and 70/70 | |
| 53 | Chr 7: 614461 to 614570 | PfEMP1 | 3 | 40% and 38/110 | |
| 54 | Chr 7: 644311 to 644440 | PfEMP1 | 8 | 41.5% and 43/130 | |
| 55 | Chr 7: 1012111 to 1012190 | Conserved GTP binding protein and cell cycle control protein cwf15 homologue | 390 and 108 | 32.5% and 44/80 | |
| 56 | Chr 7: 1145161 to 1145250 | MAL7_28Sa | 7 | 47.8% and 64/90 | |
| 57 | Chr 7: 1155801 to 1155890 | Hypothetical protein | 6 | 36.7% and 87/90 | |
| 58 | Chr 7: 1393981 to 1394050 | Hypothetical protein | 287 | 35% and 70/70 | |
| 59 | Chr 7: 1454751 to 1454820 | RIFIN | 10 | 37% and 47/70 | |
| 60 | Chr 7: 605971 to 606040 | PfEMP1 | 71 | 37% and 35/70 | |
| 61 | Chr 8: 22251 to 22330 | PfEMP1 | 39 | 41.3% and 41/80 | |
| 62 | Chr 8: 98871 to 99000 | MAL8b_28s rRNA | 176 | 36.2% and 117/130 | |
| 63 | Chr 8: 99751 to 99850 | PF08_tmp2 | 164 | 36% and 98/100 | |
| 64 | Chr 8: 187771 to 187870 | Hypothetical protein | 31% and 93/100 | ||
| 65 | Chr 8: 233921 to 233990 | Tubulin gamma chain | 45 | 35% and 66/70 | |
| 66 | Chr 8: 441381 to 441450 | PfEMP1 | 80 | 38% and 34/70 | |
| 67 | Chr 8: 1289051 to 1289130 | PF08_tmp1 r RNA and putative senescence associated protein | 225 and 129 | 50% and 53/80 | |
| 68 | Chr 8: 1289821 to 1289940 | Senescence associated protein | 163 | 40% and 116/120 | |
| 69 | Chr 8: 1290151 to 1290250 | Senescence associated protein | 493 | 37% and 96/100 | |
| 70 | Chr 8: 1399241 to 1399340 | PfEMP1 | 7 | 38% and 38/100 | |
| 71 | Chr 8: 1410561 to 1410640 | Hypothetical protein | 35% and 56/80 | ||
| 72 | Chr 8: 1412661 to 1412770 | Hypothetical protein | 10 | 38.2% and 52/110 | |
| 73 | Chr 9: 19931 to 20070 | PfEMP1 | 10 | 40.7% and 92/140 | |
| 74 | Chr 9: 42361 to 42460 | RIFIN | 449 | 34% and 80/100 | |
| 75 | Chr 9: 369131 to 369220 | Formylmethionine deformylase | 349 | 31.1% and 55/90 | |
| 76 | Chr 9: 406351 to 406460 | Transporter protein and hypothetical protein | 74 and 54 | 33.6% and 108/110 | |
| 77 | Chr 9: 632261 to 632330 | Hypothetical protein | 63 | 35% and 58/70 | |
| 78 | Chr 9: 749991 to 750080 | Large ribosomal subunit protein L3, prokaryotic (50S)like | 115 | 32.2% and 88/90 | |
| 79 | Chr 9: 757341 to 757430 | Hypothetical protein | 33.3% and 50/90 | ||
| 80 | Chr 9: 907861 to 907930 | Hypothetical protein | 37% and 64/90 | ||
| 81 | Chr 9: 1092431 to 1092510 | NAD synthase and Hypothetical protein | 11 and 324 | 32.5% and 75/80 | |
| 82 | Chr 9: 1107301 to 1107400 | Hypothetical protein | 2 | 44% and 100/100 | |
| 83 | Chr 9: 1130251 to 1130370 | Cytochrome c oxidase subunit, | 321 | 32.5% and 103/120 | |
| 84 | Chr 9: 1283801 to 1283870 | Hypothetical protein | 359 | 37% and 70/70 | |
| 85 | Chr 9: 1291101 to 1291170 | Hypothetical protein | 84 | 35% and 54/70 | |
| 86 | Chr 9: 1293991 to 1294060 | Peptide release factor and DHHC type zinc finger protein | 353 and 199 | 37% and 62/70 | |
| 87 | Chr 9: 1314241 to 1314350 | mRN A processing protein and Hypothetical protein | 526 and 192 | 35.5% and 101/110 | |
| 88 | Chr 9: 1479191 to 1479290 | RIFIN | 467 | 35% and 81/100 | |
| 89 | Chr 9: 1503331 to 1503430 | PfEMP1 | 7 | 37% and 38/100 | |
| 90 | Chr 10: 28351 to 28490 | PfEMP1 | 1 | 36.4% and 76/100 | |
| 91 | Chr 10: 39021 to 39090 | RIFIN | 17 | 35.7% and 89/100 | |
| 92 | Chr 10: 47981 to 48050 | RIFIN | 3 | 35.7% and 88/100 | |
| 93 | Chr 10: 125441 to 125510 | Hypothetical protein | 430 | 37.1% and 57/70 | |
| 94 | Chr 10: 274111 to 274200 | Hypothetical protein | 182 | 37.8% and 87/90 | |
| 95 | Chr 10: 401521 to 401590 | Hypothetical protein | 37.1% and 54/70 | ||
| 96 | Chr 10: 694111 to 694200 | Hypothetical protein | 10 | 35.6% and 50/90 | |
| 97 | Chr 10: 886941 to 887040 | Hypothetical proteins | 4 and 347 | 34% and 98/100 | |
| 98 | Chr 10: 960765 to 960854 | Hypothetical protein | 32.2% and 88/90 | ||
| 99 | Chr 10: 1162615 to 1162694 | Hypothetical protein | 35% and 79/80 | ||
| 100 | Chr 10: 1211885 to 1211964 | Hypothetical protein | 80 | 36.3% and 77/80 | |
| 101 | Chr 10: 1231655 to 1231784 | Hypothetical protein | 19 | 33.8% and 100/130 | |
| 102 | Chr 10: 1623881 to 1623950 | RIFIN | 22 | 35.7% and 98/100 | |
| 103 | Chr 11: 5321 to 5460 | Hypothetical protein | 388 | 37.1% and 115/140 | |
| 104 | Chr 11: 5631 to 5730 | Hypothetical protein | 118 | 34% and 66/100 | |
| 105 | Chr 11: 6141 to 6220 | Hypothetical protein | 51 | 35% and 65/80 | |
| 106 | Chr 11: 6311 to 6420 | Hypothetical protein | 221 and 401 | 35.5% and 73/110 | |
| 107 | Chr 11: 6581 to 6760 | Hypothetical proteins | 491 and 61 | 34.4% and 149/180 | |
| 108 | Chr 11: 6901 to 7110 | Hypothetical protein | 71 | 36.2% and 145/210 | |
| 109 | Chr 11: 7271 to 7420 | Hypothetical protein | 232 and 340 | 41.3% and 106/150 | |
| 110 | Chr 11: 7501 to 7600 | Hypothetical protein | 462 and 180 | 33% and 57/100 | |
| 111 | Chr 11: 7941 to 8210 | Hypothetical protein | 61 | 40% and 119/270 | |
| 112 | Chr 11: 8411 to 8720 | Hypothetical protein | 262 | 34.2% and 251/310 | |
| 113 | Chr 11: 18451 to 18530 | Hypothetical protein | 17 | 35% and 69/80 | |
| 114 | Chr 11: 24021 to 24150 | PfEMP1 | 10 | 49% and 67/120 | |
| 115 | Chr 11: 150597 to 150706 | Hypothetical protein | 103 | 36.4% and 107/110 | |
| 116 | Chr 11: 151007 to 151126 | Hypothetical protein | 105 | 35% and 118/120 | |
| 117 | Chr 11: 317947 to 318026 | Hypothetical protein | 99 | 32.5% and 80/80 | |
| 118 | Chr 11: 347207 to 347276 | Hypothetical protein | 240 | 37.1% and 69/70 | |
| 119 | Chr 11: 569106 to 569175 | Hypothetical protein | 56 and 220 | 35.7% and 69/70 | |
| 120 | Chr 11: 796606 to 796695 | Hypothetical protein | 173 | 35.6% and 90/90 | |
| 121 | Chr 11: 1395814 to 1395883 | Hypothetical protein | 36.8% and 66/70 | ||
| 122 | Chr 11: 1417434 to 1417503 | Hypothetical protein | 453 | 35.7% and 66/70 | |
| 123 | Chr 11: 1527984 to 1528073 | Hypothetical protein | 35.6% and 81/90 | ||
| 124 | Chr 11: 1663894 to 1664013 | Hypothetical protein | 216 | 30.8% and 117/120 | |
| 125 | Chr 11: 1918214 to 1918333 | Hypothetical protein | 217 and 74 | 33.3% and 112/120 | |
| 126 | Chr 11: 1927134 to 1927213 | Hypothetical protein | 5 and 255 | 36.3% and 44/80 | |
| 127 | Chr 11: 1929634 to 1929743 | Hypothetical protein | 58 | 38.2% and 78/110 | |
| 128 | Chr 11: 1929974 to 1930053 | Hypothetical protein | 282 | 36.3% and 58/80 | |
| 129 | Chr 11: 2010214 to 2010293 | RIFIN | 4 | 40% and 97/100 | |
| 130 | Chr 12: 32601 to 32670 | PfEMP1 | 33 | 37.1% and 41/70 | |
| 131 | Chr 12: 43711 to 43790 | RIFIN | 10 | 33.8% and 92/100 | |
| 132 | Chr 12: 774191 to 774300 | PfEMP1 | 1 | 38.2% and 53/110 | |
| 133 | Chr 12: 1360341 to 1360430 | Hypothetical protein | 190 | 34.4% and 54/90 | |
| 134 | Chr 12: 1404951 to 1405020 | Hypothetical protein | 149 | 37.1% and 67/70 | |
| 135 | Chr 12: 1529361 to 1529430 | Hypothetical protein | 379 | 37.1% and 70/70 | |
| 136 | Chr 12: 1704411 to 1704490 | PfEMP1 | 10 | 46.3% and 36/80 | |
| 137 | Chr 12: 1739561 to 1739630 | PfEMP1 | 37.5% and 35/70 | ||
| 138 | Chr 12: 2239401 to 2239480 | RIFIN | 1 | 35% and 87/100 | |
| 139 | Chr 12: 2248951 to 2249040 | PfEMP1 | 6 | 45.6% and 56/90 | |
| 140 | Chr 13: 30631 to 30700 | RIFIN | 8 | 37.1% and 94/100 | |
| 141 | Chr 13: 53591 to 53670 | RIFIN | 500 | 40% and 95/100 | |
| 142 | Chr 13: 977431 to 977520 | Aspartyl (acid) protease, putative | 55 | 38.9% and 82/90 | |
| 143 | Chr 13: 2517471 to 2517550 | Hypothetical protein | 123 | 33.8% and 79/80 | |
| 144 | Chr 13: 2791651 to 2791760 | Hypothetical protein conserved | 227 and 76 | 30.9% and 102/110 | |
| 145 | Chr 13: 2799331 to 2799400 | MAL13_5.8SrRNA rRNA | 311 | 35.7% and 57/70 | |
| 146 | Chr 14: 141091 to 141160 | Hypothetical protein and acid phosphatase | 206 and 250 | 37.1% and 62/70 | |
| 147 | Chr 14: 472871 to 472940 | GTP-binding protein, putative | 2 | 35.7% and 59/70 | |
| 148 | Chr 14: 989170 to 989279 | DNA directed DNA polymerase | 82 | 35.5% and 103/110 | |
| 149 | Chr 14: 1086373 to 1086442 | Hypothetical protein | 380 | 35.7% and 69/70 | |
| 150 | Chr 14: 1213632 to 1213711 | Hypothetical protein | 177 | 35% and 80/80 | |
| 151 | Chr 14: 1540333 to 1540412 | Translocation protein sec62, putative | 170 | 35% and 77/80 | |
| 152 | Chr 14: 2247864 to 2247933 | Protein phosphatase 2C, putative | 349 | 35.7% and 69/70 |